Efficacy of obeticholic acid treatment through 24 months of open-label extension in patients with primary biliary cholangitis and cirrhosis: Data from POISE

Category Primary study
JournalCanadian Liver Journal
Year 2018
This article has no abstract
Epistemonikos ID: a4d75c1f0916cdd6b90eef7a6939e059f9193443
First added on: Feb 11, 2025